Simmons First National (NASDAQ:SFNC) Misses Q2 CY2026 Sales Expectations

Simmons First National (SFNC) reported Q2 CY2026 sales of $248.6 million, up 12.7% year over year, but below Wall Street revenue expectations. Non-GAAP profit was $0.50 per share, 4.5% under analysts’ consensus. The article also cites TBVPS declining to $14.42 per share and a 12-month consensus TBVPS target of $15.88.

Original reporting
Published Jul 16, 2026, 9:45 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 16, 2026, 9:51 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Simmons First National (NASDAQ:SFNC) Misses Q2 CY2026 Sales Expectations — source image
Decision brief

The 30-second read

$SFNCBearishMed
01

Why it matters

Q2 CY2026 results missed revenue and non-GAAP EPS consensus, while management pointed to efficiency/rightsizing initiatives expected to fund additional investments. TBVPS has declined over both five-year and two-year windows, with consensus calling for only modest TBVPS growth over the next 12 months.

02

Market read

Traders can reassess near-term expectations for SFNC’s earnings power given the consensus miss, while also weighing management’s cost-efficiency plan and the ongoing TBVPS downtrend.

03

What to watch

The article notes net interest income is 80.6% of revenue and TBVPS has been declining, but it does not quantify loan growth, deposit costs, or credit quality, which could be the real drivers behind the miss.

Relevance 7/10Novelty 6/10Timing: after-hours/next-session reaction to Q2 CY2026 results and management commentary

Background

SFNC is a regional bank holding company, with earnings largely driven by net interest income and valued partly on tangible book value per share.

Company-level read

Ticker impact

$SFNCBearishMedium confidence
Context

Simmons First National missed Q2 CY2026 revenue and EPS consensus, with revenue up 12.7% YoY to $248.6M but below estimates.

Expected impact

Near-term downside risk from the miss, partially offset by the post-results stock pop and management’s cost-focus narrative.

Evidence & confidence

The article provides concrete miss details (revenue and EPS vs consensus) plus a same-quarter management expectation that could stabilize sentiment, but it lacks forward guidance numbers.

Market effects

Regional banks may face continued scrutiny on net interest income durability and tangible book value erosion, as highlighted by SFNC’s TBVPS declines.

Limited direct regional spillover is implied; the article is company-specific to SFNC’s multi-state footprint.

Low global relevance; this is a US regional bank earnings miss with no cross-border or macro policy catalyst described.

Counterpoint

The revenue growth rate (12.7% YoY) and the immediate 4.2% stock rise imply the market may be looking through the miss toward improving efficiency and investment capacity.

Key entities

  • Simmons First National

    Regional bank holding company reporting Q2 CY2026 revenue and non-GAAP EPS results versus Wall Street expectations.

Related articles

$SFNCMed

Why is Simmons First National stock climbing today?

Simmons First National (SFNC) stock rose 2% after Piper Sandler upgraded it to Overweight, raising its price target to $27.50. The bank plans to close 26 branches by 2026, aiming to improve efficiency. Piper Sandler increased its 2027 EPS estimate to $2.38. Keefe, Bruyette & Woods maintained a Market Perform rating but raised its target to $25.00, citing near-term costs.

$SFNCMed

SIMMONS FIRST NATIONAL CORP (SFNC): Results of Operations and Financial Condition

SIMMONS FIRST NATIONAL CORP (SFNC) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 d123214dex991.htm EX-99.1 EX-99.1 Exhibit 99.1 July 16, 2026 Simmons First National Corporation Reports Second Quarter Results F INANCIAL H IGHLIGHTS 2Q26 1Q26 2Q25 2Q26 Highlights I NCOME S TATEMENT S UMMARY (in millions) Comparisons reflect 2Q26 vs 1Q26 unless otherwi

$ALABHighAI 8/10

Why is Astera Labs stock surging today?

Astera Labs (ALAB) stock surged 12.8% after reporting Q2 2026 revenue of $392.4M, up 104% YoY, and Q3 guidance of $540M-$560M. Analysts raised price targets, with Citi at $430 and Roth Capital at $450. The company's AI products gained traction, and an upcoming conference may attract institutional interest.

$CPBHighAI 8/10

Campbell’s to hike prices, cut costs as results ‘remain unacceptable’

Campbell Soup Company (CPB) announced plans to raise prices, cut costs, and reduce its dividend by a third, citing 'unacceptable' results. The company expects fiscal 2027 sales to decline 2-4% and adjusted earnings per share of $1.65-$1.80, below estimates. Q4 net sales fell 8% to $2.14B, missing expectations. The company aims to generate $500M in cost savings by fiscal 2030.

$PLHighAI 8/10

Planet Labs Rallies 10% as Record Revenue Overrides Soft Q3 Guidance

Planet Labs (PL) stock rose 10% after reporting Q2 revenue of $116.1M, beating estimates by 11%, and adjusted EPS of $0.02, reversing a pre-earnings decline. Despite softer Q3 guidance, the company highlights a $4B sovereign satellite-services pipeline. Defense and intelligence revenue grew over 90% YoY, and non-GAAP gross margin was 59%.